Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53) - Image 1

£165.70

Springer Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Name: Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)
Brand: Springer
Price: 165.7 GBP
Availability: InStock

Pharmacy - Dispensing

About as cheap as it gets. The only time it was cheaper was 1 year ago.

£166 today · all-time low £160 (Nov 2024) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 624 days • 624 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 624 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £167-170 (282 days, 45.2%)

Price range: £160 - £177

Price levels: 5 price ranges over 624 days

Description

This book is based on invited presentations at the Ninth International Catecholamine Symposiwn. Over several decades, each International Catecholamine Symposiwn (ICS) has provided a uniquely important forwn for updating basic as well as clinical research on the catecholamines, dopamine, norepinephrine, and epinephrine. The first ICS took nd n1 place in Bethesda, Maryland, in the USA in 1958; the 2 in Milan, Italy in 1965; the 3 th in Strasbourg, France in 1973; the 4th in Asilomar, California, USA in 1978; the 5 in th th Goteborg, Sweden in 1983; the 6 in Jerusalem, Israel,in 1987; the 7 in Amsterdam, th Netherlands in 1992; and the 8 in Asilomar, California, USA in 1996. th The 9 International Catecholamine Symposiwn (9ICS) was held in Kyoto, Japan, th March 31-April 5, 2001. This ICS was held concurrently with the 5 International th Conference on Progress in Alzheimer's and Parkinson's Disease (5 ADPD). These international meetings were coordinated to be a joint international congress. Catecholamines and related neurotransmitters and neuromediators play important roles in the pathogenesis of symptoms and neurodegenerative processes of Alzheimer's disease and Parkinson's disease. Therefore, the Joint Congress provided an opportunity for investigators and clinicians working in these fields to exchange their· most recent investigational results and clinical experiences. This Joint International Congress turned out to be an enormous success, attended by 1258 participants from 38 countries, in an enthusiastic and pleasant atmosphere.

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0306474034
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 31 October 2002
Listed Since: 14 December 2006

Barcode

No barcode data available

Springer Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

About as cheap as it gets. The only time it was cheaper was 1 year ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Catecholamine Research: From Molecular Insights to Clinical Medicine: 53 (Advances in Behavioral Biology, 53)

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology)

Mapping the Progress of Alzheimer’s and Parkinson’s Disease: 51 (Advances in Behavioral Biology, 51)

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Sigma Receptors: Their Role in Disease and as Therapeutic Targets: 964 (Advances in Experimental Medicine and Biology, 964)

Neurobiology of DOPA as a Neurotransmitter

Advances in Neuropharmacology: Drugs and Therapeutics

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Central Nervous System Diseases: Innovative Animal Models from Lab to Clinic (Contemporary Neuroscience)

Alzheimer’s and Parkinson’s Diseases: Recent Developments: 44 (Advances in Behavioral Biology, 44)

Progress in Alzheimer’s and Parkinson’s Diseases: 49 (Advances in Behavioral Biology, 49)

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Parkinson's Disease and Related Disorders, Part II (Volume 84) (Handbook of Clinical Neurology, Volume 84)

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Parkinson's Disease and Movement Disorders

Horizons in Neuroscience Research. Volume 15

Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, & Potential Health Risks

Nicotinic Acetylcholine Receptors in the Nervous System: 25 (Nato ASI Subseries H:, 25)

Molecular Neuroscience

Horizons in Neuroscience Research: Volume 37